Aldabra 4 Liquidity Opportunity Vehicle, Inc. ALOV
Aldabra 4 Liquidity Opportunity Vehicle, Inc. (the "Company") is a Cayman Islands exempted company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We may pursue an initial business combination in any business or industry.
The registration statement for the Company's initial public offering (the "Initial Public Offering") became effective on January 21, 2026. On January 23, 2026, the Company consummated the Initial Public Offering of 30,015,000 units (the "Units"), including 3,915,000 Units issued pursuant to the exercise of underwriters' over-allotment option in full. Each Unit consists of one Class A ordinary share, par value $0.0001 per share (the "Class A Ordinary Shares"), and one-third of one redeemable warrant (each, a "Warrant") each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $300,150,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement of 3,126,666 warrants to Aldabra 4 LOV Sponsor Partnership, LLC (the "Sponsor") and an aggregate of 1,740,00 warrants to the underwriters (collectively, the "Private Placement Warrants") at a price of $1.50 per Private Placement Warrant, generating gross proceeds of $7,300,000 (the "Private Placement"). No underwriting discounts or commissions were paid with respect to the Private Placement.
Valuation FY2025 figures against the last close
Annual financial statements
Balance sheet
| Fiscal year | FY2025 |
|---|---|
| Cash and equivalents | $23.6K |
| Total current assets | $23.6K |
| Total assets | $285.1K |
| Accounts payable | $11.2K |
| Total liabilities | $338.1K |
| Retained earnings | -$78.1K |
| Total equity | $0 |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-036353.
Others in SIC 6770
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $647.8M | — | — |
| IACO | Idea Acquisition Corp. | $437.1M | — | — |
| KRAQ | KRAKacquisition Corp | $431.6M | — | — |
| TACO | Berto Acquisition Corp. | $393.6M | 36.2x | — |
| ALDF | Aldel Financial II Inc. | $322.7M | — | — |
| ATII | Archimedes Tech SPAC Partners II Co. | $315.1M | — | — |
| FGII | FG Imperii Acquisition Corp. | $289.7M | — | — |
| SOUL | Soulpower Acquisition Corp. | $268.0M | — | — |